Personal Capital Advisors Corp Regeneron Pharmaceuticals, Inc. Transaction History

Personal Capital Advisors Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $3.19 Million - $3.91 Million	-7,130 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $440,992 - $560,557	922 Added 14.85%	7,130 $3.45 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $3.14 Million - $3.8 Million	5,771 Added 1320.59%	6,208 $3.48 Million
Q2 2020 Aug 12, 2020	SELL	$493.32 - $643.92 $2,466 - $3,219	-5 Reduced 1.13%	437 $273,000
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $148,591 - $218,538	442 New	442 $213,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

Stay updated on Personal Capital Advisors Corp with notifications on news.